Trial intelligence / Profile preview

Thyroxine Titration Study

NCT00111735Phase 4Unknown

Sponsor
Sir Charles Gairdner Hospital
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of levothyroxine sodium in primary hypothyroidism (PH) (3 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Visual Analog Scales for Wellbeing. Status: unknown.

02

Drugs

levothyroxine sodium
03

Conditions

primary hypothyroidism (PH)

Beyond the preview

Go deeper on NCT00111735.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00111735.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call